Success Metrics

Clinical Success Rate
80.0%

Based on 8 completed trials

Completion Rate
80%(8/10)
Active Trials
1(8%)
Results Posted
75%(6 trials)
Terminated
2(17%)

Phase Distribution

Ph phase_4
1
8%
Ph phase_2
1
8%
Ph phase_3
1
8%
Ph not_applicable
9
75%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
1(8.3%)
Phase 4Post-market surveillance
1(8.3%)
N/ANon-phased studies
9(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

72.7%

8 of 11 finished

Non-Completion Rate

27.3%

3 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(8)
Terminated(3)

Detailed Status

Completed8
Terminated2
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (8.3%)
Phase 31 (8.3%)
Phase 41 (8.3%)
N/A9 (75.0%)

Trials by Status

recruiting18%
completed867%
withdrawn18%
terminated217%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DEVICE
Total Trials
12